1-20 of 28
Hui Zeng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)

Free
Keshu Zhou, Tingyu Wang, Ting Niu, Meifang Zheng, Jie Jin, Yang Liang, Rui Huang, Shuangnian Xu, Jianhua Qu, Guohui Cui, Fei Li, Yiming Luo, Ru Feng, Wenzheng Yu, Caixia Li, Zhiling Yan, Xin Zhou, Suijing Wu, Lihong Liu, Yinghua Geng, Jishi Wang, Sujun Gao, Jianfei Fu, Xiaoping Zhang, Chunyan Ji, Qianqian Xiang, Xiongpeng Zhu, Yajing Xu, Li'e Lin, Xiaoyu Zhu, Yuping Zhong, Hongling Peng, Ying Zhao, Hui Zeng, Zhao Wang, Rong Fu, Wenbin Qian, Yingmin Liang, Xiaobing Huang, Yajun Li, Min Yu, Zi Chen, Lei Wang, Lichuang Men, Zhiyan Liang, Shan Zeng, Baoer Lu, Yifan Zhai, Jianyong Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 88.
https://doi.org/10.1182/blood-2025-88
Published: 2025
Journal Articles

Efficacy and safety of a fully human BCMA CAR T-cell therapy for high-risk newly diagnosed transplant-ineligible multiple myeloma: Updated results from an open label, single-arm，phase 1 study（fumanba-2）

Free
Bing Chen, Xiaoyan Shao, Yuanyuan Jin, Yong Xu, Qinglin Shi, Chaoyang Guan, Xuxing Shen, Ping Li, Yujie Wu, Hui Zeng, Yu Zhu, Min Zhou, Lei Fan, Yaqiong Lu, Hongyu Gui, Lijuan Chen
Journal: Blood
Blood (2025) 146 (Supplement 1): 254.
https://doi.org/10.1182/blood-2025-254
Published: 2025
Journal Articles

Pola-R-CHP in previously untreated low-risk (IPI 0-1) DLBCL: A nationwide multicenter retrospective study in China

Free
Yuhong Ren, Jia Liu, Zhijuan Lin, Lihong Shou, Hui Zeng, Dong Wu, Zhiyong Zeng, Fengping Zhou, Li Bao, Hongmei Jing, Songfu Jiang, Haisheng Liu, Jianzhen Shen, Wenjuan Yu, Hui Zhou, Jingyan Xu, Yan Zhang, Ting Wang, Honghui Huang, Bing Xu, Peng Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7229.
https://doi.org/10.1182/blood-2025-7229
Published: 2025
Journal Articles

Real-World Study of Glofitamab for the Treatment of Relapse or Refractory Diffuse Large B-Cell Lymphoma in East China

Free
Jiefeng Tong, Songfu Jiang, Qian Luo, Shanhu Qian, Guifang Ouyang, Yanli Lai, Huifang Jiang, Yuxia Jiang, Hui Zeng, Baodong Ye, Wei Jiang, Wenbin Qian
Journal: Blood
Blood (2024) 144 (Supplement 1): 7762.
https://doi.org/10.1182/blood-2024-204522
Published: 2024
Journal Articles

Low-Dose Corticosteroids and Eltrombopag in the Treatment of Newly Diagnosed Adult Immune Thrombocytopenia: A Multicenter, Phase 2 Clinical Trial

Free
Qi Liu, Yingying Shen, Lihong Shou, Yongming Xia, Sai Chen, Mei Zhou, Xiaohua Xu, Liqiang Wu, Jian-Zhi Zhao, Xiaohui Dong, Linglong Xu, Chunmeng Rong, Di Qiu, Wenbin Liu, Huijin Hu, Yuechao Zhao, Yun Zhang, Linjie Li, Yaping Xie, Xiaojun Xu, Huifang Jiang, Hui Zeng, Jiaping Fu, Li Huang, Xia Lin, Dan Chen, Yuhong Zhou, Baodong Ye, Yiping Shen, Dijiong Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 3949.
https://doi.org/10.1182/blood-2024-201872
Published: 2024
Journal Articles

Loss of Cpt1a Results in Elevated Mitochondrial Reactive Oxygen Species from Glucose-Fueled Mitochondrial Oxidative Phosphorylation and Defective Hematopoietic Stem Cells

Free
Jue Li, Michihiro Hashimoto, Mingzhe Pan, Hui Zeng, Paul R. Andreassen, Gang Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4035.
https://doi.org/10.1182/blood-2024-206240
Published: 2024
Journal Articles

Updated Results from a Phase Ⅱ Clinical Trial：Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia

Free
Chuting Yang, Rui Huang, Danian Nie, Yiqing Li, Yuming Zhang, Honghua He, Chaoyang Song, Sanfang Tu, Yaling Zheng, Xuan Zhou, Jie Chen, Hui Zeng, Yuhua Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 1050.
https://doi.org/10.1182/blood-2024-201586
Published: 2024
Journal Articles

A Prospective, Multicenter, Single-Arm Study on the Combination of Orelabrutinib and Rituximab in the Second-Line Treatment of Relapsed/Refractory Marginal Zone Lymphoma

Free
Guifang Ouyang, Lixia Sheng, Jiaping Wang, Hui Zeng, Shanhao Tang, Xibin Xiao, Yamin Tan, Qunyi Guo, Yanping Shao, Minchao Yan, Wenbin Qian
Journal: Blood
Blood (2024) 144 (Supplement 1): 4391.
https://doi.org/10.1182/blood-2024-198485
Published: 2024
Journal Articles

Gilteritinib-Based Combination Therapy in Adult Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia

Free
Nianci Chen, Jiajia Pan, Yile Zhou, Liping Mao, Yinjun Lou, Jiejing Qian, Gaixiang Xu, Juying Wei, De Zhou, Lihong Shou, Huang Li, Minchao Yan, Hui Zeng, Cuihua Fan, Gongqiang Wu, Weiying Feng, Hongyan Tong, Jie Jin, Huafeng Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5926.
https://doi.org/10.1182/blood-2023-182806
Published: 2023
Journal Articles

Venetoclax Plus Azacitadine for Middle Aged and Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial

Free
Rui Huang, Xiaonan Lin, Yuming Zhang, YongZhong Su, Caixia Wang, Jihao Zhou, Zhenqian Huang, Jinxiong Huang, Xiong Zhang, Ying Zhao, Yuexiong Liang, Xiaotao Wang, Xuekui Gu, Honghua He, Yaling Zheng, Sanfang Tu, FeiHeng Chen, Shaoze Lin, Yaya Wang, Ying Dong, Pengcheng Huang, Zenghui Liu, Xiaoli Xu, Zhao Liang, Xuan Zhou, Meifang Li, Man Luo, Ming Wu, Fang Jiang, Qin Liu, Hui Zeng, Chaoyang Song, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 4263.
https://doi.org/10.1182/blood-2023-177568
Published: 2023
Journal Articles

Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Trial

Free
Chuting Yang, Yaling Zheng, Chaoyang Song, Ming Wu, Lei Wang, Xuan Zhou, Chunyan Yue, Xiaonan Lin, Jie Chen, Hui Zeng, Rui Huang, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 7045.
https://doi.org/10.1182/blood-2023-174879
Published: 2023
Journal Articles

Venetoclax Combined with HMA Versus CAG Based Chemotherapy in Acute Myeloid Leukemia: A Propensity Score Matched Analysis

Free
Xiaonan Lin, Yuming Zhang, Ying Zhao, Ying Dong, Xiaotao Wang, Pengcheng Huang, Zhenqian Huang, Honghua He, Xiaoli Xu, Yaya Wang, Fang Jiang, Hui Zeng, Rui Huang, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 2901.
https://doi.org/10.1182/blood-2023-182642
Published: 2023
Journal Articles

ABC Regimen (Azacitidine, Venetoclax and Chidamide) Is Comparable to the “3+7” Regimen in Newly Diagnosed AML: A Real-World Experience from South China

Free
Jianyu Weng, Xin Huang, Ping Wu, Chengxin Deng, Minming Li, Xiaomei Chen, Chengwei Luo, Hui Zeng, Yuming Zhang, Caixia Wang, Tingfen Deng, Lie Lin, Zhenqian Huang, Bingyi Wu, Guozheng Wang, Runhui Zheng, Xu Ye, Peilong Lai, Yang Liang, Huo Tan, Yangqiu Li, Xin Du
Journal: Blood
Blood (2023) 142 (Supplement 1): 1522.
https://doi.org/10.1182/blood-2023-188196
Published: 2023
Journal Articles

PET Tracer-Based Glucose Uptake Predicts Clinical Response to Induction Therapy in Acute Myeloid Leukaemia

Free
Hui Zeng, Suqi Deng, Juan Du, Huien Zhan, Kexiu Huang, Xue Zheng, Ying Xu, Lu Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1592.
https://doi.org/10.1182/blood-2023-189148
Published: 2023
Journal Articles

Hexamethylene Amiloride Sensitizes AML to Venetoclax through Inducing Lysosomal Membrane Permeabilization

Free
Hui Zeng, Xinya Jiang, Juan Du, Lei Hua, Xiaofan Sun, Fangshu Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 8797–8798.
https://doi.org/10.1182/blood-2022-164960
Published: 2022
Journal Articles

Hyperglycemia Induces Endothelial Dysfunction through Hedgehog Signaling-Mediated TNF-α Production

Free
Hui Zeng, Shurong Xie, Heng Wan, Heng Meng, Bo Hu, Juan Du
Journal: Blood
Blood (2022) 140 (Supplement 1): 2667–2668.
https://doi.org/10.1182/blood-2022-163132
Published: 2022
Journal Articles

Recurrent Venous and Arterial Thrombosis By Prothrombin p.R596Q Heterozygous Mutation in a Chinese Patient: A Case Report and Literature Review

Free
Rong-Fu Zhou, PhD MD, WANG JUN, MD, Xu Peng, MD, Hui Zeng, MD, Yong Xu, PhD, Yueyi Xu, MD, Min Zhou, Peipei Xu, Bing Chen
Journal: Blood
Blood (2019) 134 (Supplement_1): 4947.
https://doi.org/10.1182/blood-2019-130459
Published: 2019
Journal Articles

Compound Heterozygous Nonsense Mutations Leading to Hereditary Deficiency of Coagulation Factor XI in a Chinese Pedigree

Free
Qian Li, Hui Zeng, Yong Xu, Min Zhou, Bing Chen, Rong-Fu Zhou, PhD MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5032.
https://doi.org/10.1182/blood-2018-99-118105
Published: 2018
Journal Articles

Successful Management of a Left-Sided Endocarditis Patient Complicated with Hemophagocytic Lymphohistiocytosis---a Rare Case Report and Literature Review

Free
Qiguo Zhang, MD, Hui Zeng, MD, Peipei Xu, MD, Jing Wang, MD, Ronggong Yang, MD, Jingyan Xu, MD, Rongfu Zhou, MD, Jian Ouyan, MD, Bing Chen, MD
Journal: Blood
Blood (2016) 128 (22): 4889.
https://doi.org/10.1182/blood.V128.22.4889.4889
Published: 2016
Journal Articles

The Clinical Significance of Argonaute 2 Expression and Angiogenesis in Multiple Myeloma

Free
Qiguo Zhang, MD, Hongyan Wu, Jian Ouyang, MD, Bing Chen, MD, Haibo Dong, MD, Rong-Fu Zhou, MD, Hui Zeng, MD, Min Zhou, MD
Journal: Blood
Blood (2015) 126 (23): 5312.
https://doi.org/10.1182/blood.V126.23.5312.5312
Published: 2015